BioCryst Pharmaceuticals Days Inventory Definition
Days Inventory is also known as Days Sales of Inventory (DSI). BioCryst Pharmaceuticals's Average Total Inventories for the
three
months ended in Dec. 2023 was $29.2 Mil. BioCryst Pharmaceuticals's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $1.6 Mil.
Hence, BioCryst Pharmaceuticals's Days Inventory for the
three
months ended in Dec. 2023 was 1,625.25.
The historical rank and industry rank for BioCryst Pharmaceuticals's Days Inventory or its related term are showing as below:
BCRX'
s Days Inventory Range Over the Past 10 Years
Min: 107.23 Med: 886.32 Max: 2201.12
Current: 2198.07
During the past 13 years, BioCryst Pharmaceuticals's highest Days Inventory was 2201.12. The lowest was 107.23. And the median was 886.32.
BCRX's Days Inventory is ranked worse than 95.07% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs BCRX: 2198.07
BioCryst Pharmaceuticals's Days Inventory
increased
from Dec. 2022 (997.17) to Dec. 2023 (1,625.25).
It might indicate that BioCryst Pharmaceuticals's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioCryst Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.06.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioCryst Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.31.
BioCryst Pharmaceuticals Days Inventory Historical Data
The historical data trend for BioCryst Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioCryst Pharmaceuticals's Days Inventory
For the Biotechnology subindustry, BioCryst Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioCryst Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioCryst Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioCryst Pharmaceuticals's Days Inventory falls into.
BioCryst Pharmaceuticals Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioCryst Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioCryst Pharmaceuticals (NAS:BCRX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioCryst Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioCryst Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioCryst Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of BioCryst Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
BioCryst Pharmaceuticals (BioCryst Pharmaceuticals) Business Description
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BCRX has been successfully added to your 